These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 34858403)

  • 1. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
    Shcherbak SG; Anisenkova AY; Mosenko SV; Glotov OS; Chernov AN; Apalko SV; Urazov SP; Garbuzov EY; Khobotnikov DN; Klitsenko OA; Minina EM; Asaulenko ZP
    Front Immunol; 2021; 12():745515. PubMed ID: 34858403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
    Zhao Y; Yin L; Patel J; Tang L; Huang Y
    J Med Virol; 2021 Jul; 93(7):4358-4369. PubMed ID: 33739452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis.
    Melo AKG; Milby KM; Caparroz ALMA; Pinto ACPN; Santos RRP; Rocha AP; Ferreira GA; Souza VA; Valadares LDA; Vieira RMRA; Pileggi GS; Trevisani VFM
    PLoS One; 2021; 16(6):e0253894. PubMed ID: 34185801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine storm in severe COVID-19 pneumonia.
    Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
    J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory biomarkers and prognosis in Covid-19, where do we stand?
    Israni A; Goulden CJ; Harky A
    Rev Med Virol; 2021 Nov; 31(6):e2296. PubMed ID: 34516018
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of sarilumab and dexamethasone co-administration for lowering multiple blood biomarkers in the treatment of cytokine release syndrome in hospitalized COVID-19 patients.
    Ahmad I;
    J Pak Med Assoc; 2024 Jul; 74(7):1345-1350. PubMed ID: 39028068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico.
    Avila-Nava A; Cortes-Telles A; Torres-Erazo D; López-Romero S; Chim Aké R; Gutiérrez Solis AL
    Cytokine; 2021 Jul; 143():155543. PubMed ID: 33896708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of Association of Infection-related Biomarkers and Inflammatory Cytokines with the Severity of Coronavirus Disease 2019: A Prospective Observational Study.
    Injarapu RK; Tamboli A; Shah L; Phalgune D
    J Assoc Physicians India; 2024 Aug; 72(8):44-47. PubMed ID: 39163062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
    Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
    Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of COVID-19: Changes in laboratory parameters.
    Lagadinou M; Salomou EE; Zareifopoulos N; Marangos M; Gogos C; Velissaris D
    Infez Med; 2020 Jun; 28(suppl 1):89-95. PubMed ID: 32532944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
    Azmy V; Kaman K; Tang D; Zhao H; Dela Cruz C; Topal JE; Malinis M; Price CC
    J Clin Immunol; 2021 May; 41(4):738-747. PubMed ID: 33459964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?
    Vaira LA; De Vito A; Deiana G; Pes C; Giovanditto F; Fiore V; Lechien JR; Saussez S; Policicchio D; Boccaletti R; Madeddu G; Babudieri S; Pazzola A; Bandiera F; Fois AG; Piana AF; Hopkins C; De Riu G
    J Laryngol Otol; 2021 Aug; 135(8):723-728. PubMed ID: 34184623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.
    Liu Y; Chen D; Hou J; Li H; Cao D; Guo M; Ling Y; Gao M; Zhou Y; Wan Y; Zhu Z
    Cytokine; 2021 Feb; 138():155365. PubMed ID: 33246770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory biomarkers associated with COVID-19 severity and management.
    Keddie S; Ziff O; Chou MKL; Taylor RL; Heslegrave A; Garr E; Lakdawala N; Church A; Ludwig D; Manson J; Scully M; Nastouli E; Chapman MD; Hart M; Lunn MP
    Clin Immunol; 2020 Dec; 221():108614. PubMed ID: 33153974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 associated pulmonary embolism: clinical, biochemical and CT imaging findings.
    Dumea E; Lazar M; Chitu-Tisu CE; Barbu EC; Ion DA
    Rom J Intern Med; 2024 Sep; 62(3):307-322. PubMed ID: 38641909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of type III interferons in patients with severe COVID-19.
    Fukuda Y; Homma T; Inoue H; Onitsuka C; Ikeda H; Goto Y; Sato Y; Kimura T; Hirai K; Ohta S; Yamamoto M; Kusumoto S; Suzuki S; Tanaka A; Sagara H
    J Med Virol; 2021 Jul; 93(7):4559-4563. PubMed ID: 33811680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing Correlation of Clinical Severity of COVID-19 with Other Biochemical Parameters: A Retrospective Study from Pakistan.
    Hassan Shah SST; Naeem I; Wahid B
    Tohoku J Exp Med; 2021 Dec; 255(4):315-323. PubMed ID: 34911879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological findings and complications of COVID-19.
    Terpos E; Ntanasis-Stathopoulos I; Elalamy I; Kastritis E; Sergentanis TN; Politou M; Psaltopoulou T; Gerotziafas G; Dimopoulos MA
    Am J Hematol; 2020 Jul; 95(7):834-847. PubMed ID: 32282949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.